PA8577201A1 - 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b - Google Patents

3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b

Info

Publication number
PA8577201A1
PA8577201A1 PA20038577201A PA8577201A PA8577201A1 PA 8577201 A1 PA8577201 A1 PA 8577201A1 PA 20038577201 A PA20038577201 A PA 20038577201A PA 8577201 A PA8577201 A PA 8577201A PA 8577201 A1 PA8577201 A1 PA 8577201A1
Authority
PA
Panama
Prior art keywords
phenyl
propionamide
derivatives
acrylamid
mao
Prior art date
Application number
PA20038577201A
Other languages
English (en)
Inventor
Rene Wyler
Andrew William Thomas
Rosa Maria Rodriguez Sarmiento
Synese Jolidon
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8577201A1 publication Critical patent/PA8577201A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Abstract

3-FENIL-PROPIONAMIDO, 3-FENIL-ACRILAMIDO Y DERIVADOS DE 3-FENIL-PROPIONAMIDO, PROCESOS PARA SU PREPARACION, COMPOSICIONES QUE LOS CONTIENEN Y EL USO DE TALES DERIVADOS COMO INHIBIDORES DE MAO-B.
PA20038577201A 2002-07-15 2003-07-10 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b PA8577201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02015583 2002-07-15

Publications (1)

Publication Number Publication Date
PA8577201A1 true PA8577201A1 (es) 2004-02-07

Family

ID=30011071

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038577201A PA8577201A1 (es) 2002-07-15 2003-07-10 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b

Country Status (20)

Country Link
US (1) US6900354B2 (es)
EP (1) EP1523469B1 (es)
JP (1) JP4108679B2 (es)
KR (1) KR20050029206A (es)
CN (1) CN1305838C (es)
AR (1) AR040489A1 (es)
AT (1) ATE410407T1 (es)
AU (1) AU2003281030B2 (es)
BR (1) BR0312658A (es)
CA (1) CA2493372A1 (es)
DE (1) DE60323981D1 (es)
ES (1) ES2314219T3 (es)
MX (1) MXPA05000583A (es)
PA (1) PA8577201A1 (es)
PE (1) PE20040667A1 (es)
PL (1) PL373390A1 (es)
RU (1) RU2318802C2 (es)
TW (1) TW200404760A (es)
UY (1) UY27894A1 (es)
WO (1) WO2004007429A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588704A1 (en) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
MY149038A (en) * 2004-05-26 2013-07-15 Eisai R&D Man Co Ltd Cinnamide compound
KR20070083781A (ko) * 2004-10-26 2007-08-24 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물의 비정질체
RU2007129642A (ru) 2005-02-25 2009-03-27 Ф.Хоффманн-Ля Рош Аг (Ch) Таблетки с улучшенным распределением лекарственного вещества
WO2006127133A2 (en) 2005-04-01 2006-11-30 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US8138209B2 (en) * 2005-07-13 2012-03-20 Jenrin Discovery, Inc. Substituted picolinamides as MAO-B inhibitors useful for treating obesity
PL209602B1 (pl) 2005-10-20 2011-09-30 Inst Chemii Bioorg Pan Sposób otrzymywania amidu kwasu 3-(4-hydroksyfenylo)propanowego
JPWO2007058304A1 (ja) * 2005-11-18 2009-05-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物の塩またはそれらの溶媒和物
EP1950211A4 (en) * 2005-11-18 2011-08-31 Eisai R&D Man Co Ltd PROCESS FOR PREPARING A CINEMA ACID AMID DERIVATIVE
CN101312965B (zh) * 2005-11-24 2011-07-20 卫材R&D管理有限公司 吗啉型肉桂酰胺化合物
BRPI0618814A2 (pt) * 2005-11-24 2014-04-29 Eisai R&D Man Co Ltd Composto ou um sal farmacologicamente aceitável do mesmo, e, agente farmacêutico
TWI370130B (en) * 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
AR062095A1 (es) * 2006-07-28 2008-10-15 Eisai R&D Man Co Ltd Profarmaco de compuesto cinamida
US20080207900A1 (en) * 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
CA2687262A1 (en) * 2007-05-16 2008-11-20 Naoyuki Shimomura One-pot production process for cinnamide derivative
US7986144B2 (en) * 2007-07-26 2011-07-26 Schlumberger Technology Corporation Sensor and insulation layer structure for well logging instruments
CL2008002542A1 (es) 2007-08-31 2009-01-02 Eisai R&D Man Co Ltd Compuestos derivados de imidazolil piridina ligados a un heterociclo mediante un vinilo, moduladores de la actividad de amiloide-beta; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de enfermedades tales como alzheimer, demencia, sindrome de down o amiloidosis.
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
EP2239265A1 (en) * 2008-01-28 2010-10-13 Eisai R&D Management Co., Ltd. Crystalline cinnamide compounds or salts thereof
NL2005655A (en) 2009-12-09 2011-06-14 Asml Netherlands Bv A lithographic apparatus and a device manufacturing method.
CN104030941B (zh) * 2014-06-23 2016-04-27 常州大学 一种3-（4-羟基苯基）丙酰胺的合成方法
CN107011313B (zh) * 2016-01-27 2021-11-30 天士力医药集团股份有限公司 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用
KR20200108015A (ko) 2018-01-10 2020-09-16 브라이트씨드, 인크. 대사를 조절하기 위한 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645019A1 (es) * 1989-03-30 1990-10-05 Fournier Innovation Synergie
US5679715A (en) 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
JP3258027B2 (ja) 1996-03-15 2002-02-18 サマーセット・ファーマシューティカルズ・インコーポレイテッド セレジリン投与による末梢ニューロパシーの予防および治療方法
AU1359801A (en) 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome

Also Published As

Publication number Publication date
RU2318802C2 (ru) 2008-03-10
PL373390A1 (en) 2005-08-22
CN1665774A (zh) 2005-09-07
PE20040667A1 (es) 2004-09-25
US6900354B2 (en) 2005-05-31
JP2005533092A (ja) 2005-11-04
AU2003281030B2 (en) 2009-05-28
DE60323981D1 (de) 2008-11-20
BR0312658A (pt) 2005-04-26
TW200404760A (en) 2004-04-01
CA2493372A1 (en) 2004-01-22
MXPA05000583A (es) 2005-04-19
ATE410407T1 (de) 2008-10-15
JP4108679B2 (ja) 2008-06-25
AU2003281030A1 (en) 2004-02-02
UY27894A1 (es) 2003-12-31
WO2004007429A1 (en) 2004-01-22
RU2005104104A (ru) 2005-10-10
ES2314219T3 (es) 2009-03-16
EP1523469A1 (en) 2005-04-20
CN1305838C (zh) 2007-03-21
AR040489A1 (es) 2005-04-06
US20040034096A1 (en) 2004-02-19
KR20050029206A (ko) 2005-03-24
EP1523469B1 (en) 2008-10-08

Similar Documents

Publication Publication Date Title
UY27894A1 (es) Derivados de cinamida.
UY28342A1 (es) Nuevos compuestos
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
ECSP077271A (es) Derivados de pirimidina
ECSP077259A (es) Derivados de pirimidina
GT200500275A (es) Nuevos herbicidas
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
UY29781A1 (es) Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos
UY28572A1 (es) Compuestos novedosos
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
CR9786A (es) Compuestos de bencimidazol-tiofeno
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
UY30976A1 (es) Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones.
UY29732A1 (es) Derivados de benzotiazolonas, procesos de preparación, composiciones y combinaciones que los contienen y aplicaciones
HN1999000106A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
UY29607A1 (es) Compuestos quimicos
ECSP11011344A (es) Nuevos anticuerpos anti-?5?1 y sus usos
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP088584A (es) Nuevos derivados de benzimidazol como inhibidores del receptor vanilloide 1 (vrl)
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
UY28670A1 (es) Arilpirazoles sustituidos
GT200600123A (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como inhibidor de la inflamacion